111043-06-2

Basic information

• Product Name: 1-(3-BROMOPYRIDIN-4-YL)ETHANONE
• Synonyms: 1-(3-BROMOPYRIDIN-4-YL)ETHANONE;1-(3-broMo-4-pyridinyl)ethanone;4-Acetyl-3-broMopyridine;1-(2-BroMo-pyridin-4-yl)-ethanone;ETHANAONE, 1-(3-BROMO-4-PYRIDINYL)-;1-(3-Bromopyridin-4-yl)ethan-1-one
• CAS NO: 111043-06-2
• Molecular Formula: C₇H₆BrNO
• Molecular Weight: 200.03264
• Mol File: 111043-06-2.mol
• Article Data: 20

Chemical Properties

• Boiling Point: 265.0±25.0 °C(Predicted)
• Appearance: /
• Density: 1.534±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 1.17±0.18(Predicted)
• CAS DataBase Reference: 1-(3-BROMOPYRIDIN-4-YL)ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-BROMOPYRIDIN-4-YL)ETHANONE(111043-06-2)
• EPA Substance Registry System: 1-(3-BROMOPYRIDIN-4-YL)ETHANONE(111043-06-2)

Safety Data

• Hazardous Substances Data: 111043-06-2(Hazardous Substances Data)

Usage

General Description

1-(3-Bromopyridin-4-yl)ethanone is a chemical compound with the formula C8H7BrNO. It is an organic compound that belongs to the class of ketones, which are characterized by a carbonyl group bonded to two alkyl or aryl groups. The compound contains a pyridine ring with a bromine atom in the 3-position, and a ketone group at the 4-position. It is commonly used as a building block in the synthesis of pharmaceuticals and other organic compounds. The compound is known for its versatile reactivity and is used in various chemical and pharmaceutical applications. Additionally, it is important to handle this chemical with care as it is toxic and can cause irritation to the skin, eyes, and respiratory system if not handled properly.

InChI:InChI=1S/C7H6BrNO/c1-5(10)6-2-3-9-4-7(6)8/h2-4H,1H3

Upstream product

• 118289-17-1 2-bromopyridine-4-carboxaldehyde 
• 66572-56-3 2-bromoisonicotinic acid 
• 1220126-97-5 1-(2-bromopyridin-4-yl)ethan-1-ol 
• 656257-69-1 2-bromo-N-methyl-N-(methyloxy)-4-pyridinecarboxamide 
• 75-16-1 methylmagnesium bromide 
• 58530-53-3 2,4-dibromopyridine 
• 127-19-5 N,N-dimethyl acetamide 
• 917-64-6 methyl magnesium iodide 
• 1122-54-9 methyl (4-pyridyl) ketone 
• 78948-09-1 acetyl hypofluorite 
• 149227-04-3 1-(3-bromopyridin-4-yl)ethan-1-ol 
• 70201-43-3 3-bromo-pyridine-4-carbaldehyde 
• 13959-02-9 3-bromoisonicotinic acid 
• 909532-61-2 3-bromo-N-methyl-N-(methyloxy)-4-pyridinecarboxamide 

Downstream Products

• 1187669-62-0 4-(3-ethyl-4-pyridinyl)-N-(3-methylphenyl)-1,3-thiazol-2-amine 
• 1187669-61-9 4-(3-ethynyl-4-pyridinyl)-N-(3-methylphenyl)-1,3-thiazol-2-amine 
• 1187669-64-2 3-(4-{2-[(3-methylphenyl)amino]-1,3-thiazol-4-yl}-3-pyridinyl)-1-propanol 
• 1187669-63-1 3-(4-{2-[(3-methylphenyl)amino]-1,3-thiazol-4-yl}-3-pyridinyl)-2-propyn-1-ol 
• 1055073-69-2 2-(2-bromopyridin-4-yl)-propan-2-ol 
• 1187669-38-0 4-(2-bromo-4-pyridinyl)-N-(3-methylphenyl)-1,3-thiazol-2-amine 
• 1187669-43-7 4-(2-ethyl-4-pyridinyl)-N-(3-methylphenyl)-1,3-thiazol-2-amine 
• 1187669-71-1 N,N-dimethyl-4-{2-[(3-methylphenyl)amino]-1,3-thiazol-4-yl}-pyridin-2-amine 
• 1187669-42-6 4-(2-ethynyl-4-pyridinyl)-N-(3-methylphenyl)-1,3-thiazol-2-amine 
• 1187669-45-9 3-(4-{2-[(3-methylphenyl)amino]-1,3-thiazol-4-yl}-2-pyridinyl)-1-propanol 
• 1187669-44-8 3-(4-{2-[(3-methylphenyl)amino]-1,3-thiazol-4-yl}-2-pyridinyl)-2-propyn-1-ol 
• 1187669-69-7 N-(3-methylphenyl)-4-[2-morpholin-4-yl-pyridin-4-yl]-1,3-thiazol-2-amine 
• 1187669-70-0 N-(3-methylphenyl)-4-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1,3-thiazol-2-amine 
• 1366407-37-5 1-[2-(4-fluorophenyl)pyridin-4-yl]ethanone 

Relevant articles and documents

Aminopyridyloxypyrazole derivative and preparation method and application thereof

The invention relates to an aminopyridyloxypyrazole derivative and a preparation method and application thereof. The structure of the aminopyridyloxypyrazole derivative is shown as a formula (I). The invention provides a brand-new aminopyridyloxypyrazole derivative which has obvious effects of inhibiting TGF [beta] R1 (ALK5) kinase activity and treating cancer or fibrosis related diseases, and the preparation method of the derivative is simple and easy to operate.

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.

PYRIDINYL PYRAZOLES AS MODULATORS OF RORyT

The present invention comprises compounds of Formula I. wherein: R1, R3, R4, R5, R6, and Q are defined in the specification. The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.